New diabetes clinical trial: A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Published on: August 02, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Insulin Degludec/Insulin Aspart
Sponsor:   Novo Nordisk A/S
Enrolling by invitation